GTEx Lung 20-29 vs 50-59 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Lung 20-29 vs 50-59 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Lung 20-29 vs 50-59 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Lung 20-29 vs 50-59 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Lung 20-29 vs 50-59 Down.

Results found

Linked to

 

Label

Description

 

Gene

tripartite motif containing 15

Gene

HHIP antisense RNA 1

Gene

rhabdomyosarcoma 2 associated transcript

Gene

long intergenic non-protein coding RNA 460

Gene

TMEM105 long non-coding RNA

Gene

G protein pathway suppressor 2 pseudogene 1

Gene

uncharacterized LOC100129540

Gene

prostate and testis expressed opposite C1QTNF9B and MIPEP

Gene

ROR1 antisense RNA 1

Gene

uncharacterized MGC27382

  • Gene

    tripartite motif containing 15


  • Gene

    HHIP antisense RNA 1


  • Gene

    rhabdomyosarcoma 2 associated transcript


  • Gene

    long intergenic non-protein coding RNA 460


  • Gene

    TMEM105 long non-coding RNA


  • Gene

    G protein pathway suppressor 2 pseudogene 1


  • Gene

    uncharacterized LOC100129540


  • Gene

    prostate and testis expressed opposite C1QTNF9B and MIPEP


  • Gene

    ROR1 antisense RNA 1


  • Gene

    uncharacterized MGC27382

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.